Skip to main content
Premium Trial:

Request an Annual Quote

Luminex Finalizes Compensation for Board of Directors

NEW YORK, March 18 (GenomeWeb News) - In an 8-K form filed with the US Securities and Exchange Commission yesterday, Luminex disclosed the terms of compensation to be paid to its non-employee directors.


The chairman of the company's board of directors, Walter Loewenbaum, will receive a monthly retainer of $10,000. Loewenbaum has served as a member of the board since 1995.


Board members other than the chairman will receive an annual retainer of $18,000.


Chairs of the audit committee and executive committee of the board of directors will be paid an additional annual retainer of $20,000, while the chair of the compensation and nominating and corporate governance committees will be paid an additional annual retainer of $10,000.


Each board member will also receive $2,000 for each board meeting attended, $500 for each committee meeting, and $1,000 for each audit committee meeting.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.